Geode Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Buy |
1,797,215
+141,551
| +9% | +$1.86M | ﹤0.01% | 1875 |
|
|
2025
Q1 | $36.4M | Buy |
1,655,664
+55,093
| +3% | +$1.21M | ﹤0.01% | 1564 |
|
|
2024
Q4 | $42.7M | Buy |
1,600,571
+1,036
| +0.1% | +$27.7K | ﹤0.01% | 1525 |
|
|
2024
Q3 | $42.7M | Sell |
1,599,535
-73,118
| -4% | -$1.95M | ﹤0.01% | 1518 |
|
|
2024
Q2 | $30.1M | Buy |
1,672,653
+302,756
| +22% | +$5.45M | ﹤0.01% | 1696 |
|
|
2024
Q1 | $25M | Buy |
1,369,897
+422,851
| +45% | +$7.71M | ﹤0.01% | 1790 |
|
|
2023
Q4 | $10.4M | Buy |
947,046
+55,278
| +6% | +$605K | ﹤0.01% | 2325 |
|
|
2023
Q3 | $5.11M | Buy |
891,768
+35,556
| +4% | +$204K | ﹤0.01% | 2628 |
|
|
2023
Q2 | $6.64M | Buy |
856,212
+80,725
| +10% | +$626K | ﹤0.01% | 2542 |
|
|
2023
Q1 | $5.17M | Buy |
775,487
+53,342
| +7% | +$356K | ﹤0.01% | 2614 |
|
|
2022
Q4 | $6.46M | Buy |
722,145
+198,624
| +38% | +$1.78M | ﹤0.01% | 2514 |
|
|
2022
Q3 | $5.15M | Buy |
523,521
+126,691
| +32% | +$1.25M | ﹤0.01% | 2659 |
|
|
2022
Q2 | $3.16M | Sell |
396,830
-41,311
| -9% | -$329K | ﹤0.01% | 2949 |
|
|
2022
Q1 | $4.25M | Buy |
438,141
+46,559
| +12% | +$452K | ﹤0.01% | 2890 |
|
|
2021
Q4 | $5.98M | Buy |
391,582
+148,663
| +61% | +$2.27M | ﹤0.01% | 2795 |
|
|
2021
Q3 | $4.03M | Buy |
242,919
+497
| +0.2% | +$8.25K | ﹤0.01% | 3037 |
|
|
2021
Q2 | $5.17M | Buy |
+242,422
| New | +$5.17M | ﹤0.01% | 2880 |
|